Speculative Buy below 50 cents is the call on Westpac broking.
BTC is one of Australia's pure biotechnology investment funds. It offers retail investors exposure to a diversified portfolio of unlisted opportunities and listed companies. The big appreciation in value of R&D companies that occurs before and at the time of listing is generally not available to retail investors. Listed investee companies include Alchemia, Starpharma, Clinical Cell Culture, Prima Biomed and Phylogica. BTC is high risk, but could generate well-above average returns. Shareholders need to take a medium to long-term view.
The vast majority of investors will lose money in the biotech sector if they invest directly. BTC management has industry expertise and a wide information network that along with its ability to tap into unlisted companies provide it with a much better chance of generating attractive returns
I like companies that give a lot of exposure.
Love ARGO investments that basically investments in the top companies...
Dont know a heap about BTC but would be keen to find out more.